UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

Leukemia, 2016-04, Vol.30 (4), p.889-896

2016

Volltextzugriff (PDF)

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Leukemia, 2014-05, Vol.28 (5), p.1033-1040

2014

Volltextzugriff (PDF)

Erythropoietin, iron, and erythropoiesis

Blood, 2000-08, Vol.96 (3), p.823-833

2000

Volltextzugriff (PDF)

P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON

HemaSphere, 2022-06, Vol.6, p.470-471

2022

Volltextzugriff (PDF)

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Leukemia, 2015-12, Vol.29 (12), p.2452-2452

2015

Volltextzugriff (PDF)

Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction

International journal of laboratory hematology, 2012-10, Vol.34 (5), p.525-532

2012

Volltextzugriff (PDF)

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL OF ORAL AZACITIDINE

HemaSphere, 2022-06, Vol.6, p.397-398

2022

Volltextzugriff (PDF)

115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q)

Leukemia research, 2015-04, Vol.39, p.S59-S59

2015

Volltextzugriff (PDF)

Serum Transferrin Receptor: A Quantitative Measure of Tissue Iron Deficiency

Blood, 1990-05, Vol.75 (9), p.1870-1876

1990

Volltextzugriff (PDF)

Serum Transferrin Receptor

Annual review of medicine, 1993-01, Vol.44 (1), p.63-74

1993

Volltextzugriff (PDF)

116 THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MDS: RESULTS FROM THE MDS-005 TRIAL

Leukemia research, 2015-04, Vol.39, p.S60-S60

2015

Volltextzugriff (PDF)

P-197 A study of gastric acid pH modulation on the pharmacokinetics of oral azacitidine (CC-486) in subjects with hematologic malignancies

Leukemia research, 2013-05, Vol.37, p.S112-S113

2013

Volltextzugriff (PDF)

Circulating transferrin receptor assay--coming of age

Clinical chemistry (Baltimore, Md.), 1998-01, Vol.44 (1), p.7-9

Skikne, B S

1998

Volltextzugriff (PDF)

Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature

Bone marrow transplantation (Basingstoke), 2003-01, Vol.31 (1), p.57-60

2003

Volltextzugriff (PDF)

Oral and Parenteral Glutamine in Bone Marrow Transplantation: A Randomized, Double-Blind Study

JPEN. Journal of parenteral and enteral nutrition, 1999-05, Vol.23 (3), p.117-122

1999

Volltextzugriff (PDF)

221 Occurrence of trisomy 8 (+8) in patients with Low- or Int-1-risk MDS with deletion 5q [del(5q)] treated with lenalidomide

Leukemia research, 2011, Vol.35, p.S87-S87

2011

Volltextzugriff (PDF)

Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection

Transplant infectious disease, 2008-02, Vol.10 (1), p.56-58

2008

Volltextzugriff (PDF)

181 Oral azacitidine is bioavailable and reduces DNA methylation at low doses in extended schedules: Phase I study results

Leukemia research, 2011-05, Vol.35, p.S71-S71

2011

Volltextzugriff (PDF)

POSC108 Estimated Hospitalization-Related Costs with Oral Azacitidine (ORAL-AZA) vs. Placebo for Remission Maintenance in Patients with Acute Myeloid Leukemia (AML) in Sweden and Norway

Value in health, 2022-01, Vol.25 (1), p.S108-S108

2022

Volltextzugriff (PDF)

Iron deficiency: definition and diagnosis

Journal of internal medicine, 1989-11, Vol.226 (5), p.349-355

1989

Volltextzugriff (PDF)

Serum transferrin receptor is a truncated form of tissue receptor

The Journal of biological chemistry, 1990-11, Vol.265 (31), p.19077-19081

1990

Volltextzugriff (PDF)

Iron deficiency: the global perspective

Advances in experimental medicine and biology, 1994, Vol.356, p.219

1994

Volltextzugriff (PDF)

Serum transferrin receptor for the detection of iron deficiency in pregnancy

The American journal of clinical nutrition, 1991-12, Vol.54 (6), p.1077-1081

1991

Volltextzugriff (PDF)

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure

American journal of kidney diseases, 1997-10, Vol.30 (4), p.532-541

1997

Volltextzugriff (PDF)

The quantitative assessment of body iron

Blood, 2003-05, Vol.101 (9), p.3359-3364

2003

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(134)
Tagungsberichte
(2)

Sprache

Englisch
(136)

Erscheinungsjahr

n.n

Thema

Humans
(81)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Male
(50)
Female
(49)
Adult
(47)
Biological And Medical Sciences
(45)
Middle Aged
(39)
Medical Sciences
(33)
Hematology
(32)
General & Internal Medicine
(19)
Aged
(18)
Ferritins - Blood
(18)
Medicine, General & Internal
(18)
Iron - Metabolism
(17)
Iron - Blood
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Hematologic And Hematopoietic Diseases
(12)
Animals
(11)
Intestinal Absorption
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Erythropoietin, iron, and erythropoiesis

P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG‐TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML‐001 TRIAL OF ORAL AZACITIDINE

115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q)

Serum Transferrin Receptor: A Quantitative Measure of Tissue Iron Deficiency

Serum Transferrin Receptor

116 THE EFFECT OF LENALIDOMIDE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MDS: RESULTS FROM THE MDS-005 TRIAL

P-197 A study of gastric acid pH modulation on the pharmacokinetics of oral azacitidine (CC-486) in subjects with hematologic malignancies

Circulating transferrin receptor assay--coming of age

Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature

Oral and Parenteral Glutamine in Bone Marrow Transplantation: A Randomized, Double-Blind Study

221 Occurrence of trisomy 8 (+8) in patients with Low- or Int-1-risk MDS with deletion 5q [del(5q)] treated with lenalidomide

Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection

181 Oral azacitidine is bioavailable and reduces DNA methylation at low doses in extended schedules: Phase I study results

POSC108 Estimated Hospitalization-Related Costs with Oral Azacitidine (ORAL-AZA) vs. Placebo for Remission Maintenance in Patients with Acute Myeloid Leukemia (AML) in Sweden and Norway

Iron deficiency: definition and diagnosis

Serum transferrin receptor is a truncated form of tissue receptor

Iron deficiency: the global perspective

Serum transferrin receptor for the detection of iron deficiency in pregnancy

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure

The quantitative assessment of body iron

Suchergebnisse filtern